| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/17/2007 | US20070112029 Piperidine compound and process for preparing the same |
| 05/17/2007 | US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma |
| 05/17/2007 | US20070111951 Novel galactosylceramide analogues, and beta-glucocerebrosidase activator, external skin preparations and method of activating beta-glucocerebrosidase using the same |
| 05/17/2007 | US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 05/17/2007 | US20070111931 Compositions and methods for promoting wound healing and tissue repair |
| 05/17/2007 | US20070111266 Antibodies to murine zcytor17 ligand |
| 05/17/2007 | US20070110704 Combination of 2,3-dibenzylbutyrolactone and licochalcone-a |
| 05/17/2007 | US20070110698 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/16/2007 | EP1785134A2 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/16/2007 | EP1785132A1 Constitutional function-improving agents |
| 05/16/2007 | EP1784391A1 Phenanthridine carbonyl phenols as cytokine expression modulators |
| 05/16/2007 | EP1784223A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 05/16/2007 | EP1784205A1 Stretch mark treatment with botulinum toxic |
| 05/16/2007 | EP1784182A1 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 05/16/2007 | EP1784181A1 Vegf inhibition |
| 05/16/2007 | EP1539201A4 Antipyrotic and method of manufacturing the same |
| 05/16/2007 | EP1536807A4 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 05/16/2007 | EP1490092B1 Cosmetic or pharmaceutical composition containing peptides |
| 05/16/2007 | EP1455805B1 A process for obtaining a zinc oxide containing product for skin-healing, care and protection in children and adults |
| 05/16/2007 | EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 05/16/2007 | EP1305285B1 N-substituted indoles useful in the treatment of diabetes |
| 05/16/2007 | EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 05/16/2007 | EP0989853B1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 05/16/2007 | CN1964964A Piperidine derivates for the treatment of chemokines mediared disease |
| 05/16/2007 | CN1964705A Methods for interfering with fibrosis |
| 05/16/2007 | CN1962745A Water-based composition containing hydroxy and its uses |
| 05/16/2007 | CN1962641A Metalloproteinase inhibitors |
| 05/16/2007 | CN1961958A Method for improving cicatrisation of wound |
| 05/16/2007 | CN1961947A Chinese medicine capable of treating depression and beautifying face and preparation method thereof |
| 05/16/2007 | CN1961946A Medicament for treating tumor and ulcer and preparation method thereof |
| 05/16/2007 | CN1961945A Herbal liquor impregnated agent cover |
| 05/16/2007 | CN1961930A Bedsore treatment liquid with centipede and preparation method thereof |
| 05/16/2007 | CN1961926A Medicament for treating acne |
| 05/16/2007 | CN1961925A A stasis-resolving spot-removing medicament and preparation method thereof |
| 05/16/2007 | CN1961893A Method for preparing extract of adult bombay canary |
| 05/16/2007 | CN1961891A Radiation resistant composition |
| 05/16/2007 | CN1961884A Powder for treating scald |
| 05/16/2007 | CN1961882A Method for preparing minoxidil tincture |
| 05/16/2007 | CN1961715A Fox fur nutrition enhancer |
| 05/16/2007 | CN1315847C 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315840C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives used as drug for treating pain |
| 05/16/2007 | CN1315838C 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315836C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/16/2007 | CN1315833C Azaindole kinase inhibitors |
| 05/16/2007 | CN1315832C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives |
| 05/16/2007 | CN1315822C Quinoline derivatives having VEGF inhibiting activity |
| 05/16/2007 | CN1315496C Embedding catgut soaking liquor for treating psoriasis and its preparation method |
| 05/16/2007 | CN1315490C Medicine for treating knife wound and other wounds and its preparation |
| 05/16/2007 | CN1315484C Pharmaceutical vector composition for treating dermatopathy and process for preparing same |
| 05/16/2007 | CN1315479C Use of oleuropein in preparation of drug for inhibiting angiogenesis |
| 05/16/2007 | CN1315457C Bath liquid used for frostbite nursing and its preparation method |
| 05/16/2007 | CN1315454C Topical compositions for regulating oily/shiny appearance of skin |
| 05/15/2007 | USRE39634 treatment of neuropathic pain; elevate levels of anandamide or other endogenous cannabinoids to increase the nociceptive threshold |
| 05/15/2007 | US7217821 sunscreen agents; prevent radiation damage to skin, hair, lips |
| 05/15/2007 | US7217820 Protective coatings for skin, hair, for use as ultravilotet radiation filters in cosmetic or pharmaceutical preparations for protecting human skin or human hair against solar rays |
| 05/15/2007 | US7217796 Neutralizing human anti-IGFR antibody |
| 05/15/2007 | US7217736 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 05/15/2007 | US7217732 Cannabinoid receptor agonists |
| 05/15/2007 | US7217729 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies |
| 05/15/2007 | US7217728 For therapy of reperfusion injury |
| 05/15/2007 | US7217707 Amide of R-2-(aminoaryl)-propionic acid for use in the prevention of leucocyte activation |
| 05/15/2007 | US7217534 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 05/15/2007 | US7217422 Compositions and methods for enhancing corticosteroid delivery |
| 05/15/2007 | US7217416 Use of gamma globulin for the topical treatment of lesions of dermatitis |
| 05/15/2007 | CA2437844C Method for increasing leptin levels using nicotinic acid compounds |
| 05/15/2007 | CA2392973C Benzoimidazole derivatives useful as antiproliferative agents |
| 05/15/2007 | CA2366829C Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 05/15/2007 | CA2366186C Retinoid antagonists and use thereof |
| 05/15/2007 | CA2281944C Methods and compositions for preventing and treating chronological aging in human skin |
| 05/15/2007 | CA2266811C Method and composition for wound treatment |
| 05/15/2007 | CA2176948C Chaperonin 10 |
| 05/10/2007 | WO2007052793A1 Patch |
| 05/10/2007 | WO2007052740A1 Equol level regulator |
| 05/10/2007 | WO2007051836A2 Compositions for treating dermatological and neurological disorders |
| 05/10/2007 | WO2007051596A1 Novel retinyl biotinates and use thereof |
| 05/10/2007 | WO2007051586A1 Bacteriostatic and/or bactericide agent for cosmetic and/or dermopharmaceutical preparations and preparations containing this agent |
| 05/10/2007 | WO2007027092A3 Oral composition for moisturising skin |
| 05/10/2007 | WO2007025897A3 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 05/10/2007 | WO2007020286A3 Method of using potassium channel inhibiting compounds |
| 05/10/2007 | WO2006105313A3 Compositions of and methods of using oversulfated glycosaminoglycans |
| 05/10/2007 | US20070105958 Compounds for the treatment of metabolic disorders |
| 05/10/2007 | US20070105949 Intermediates for the preparation of lipoxin A4 analogs |
| 05/10/2007 | US20070105936 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 05/10/2007 | US20070105933 Amino alcohol compounds |
| 05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
| 05/10/2007 | US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors |
| 05/10/2007 | US20070105858 Retinoic acid mimetic anilides |
| 05/10/2007 | US20070105191 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector |
| 05/10/2007 | US20070104676 Applying the extract; skin, scalp and hair for soothing irritations, skin aging, reducing inflammation and treatment of itching and flaking of the scalp |
| 05/10/2007 | DE202007000181U1 Zubereitungen (Pharmazeutika, Desinfektionsmittel, Pflege- und Hygienemittel, Wundtherapeutika) mit Carvacrol, Shea Butter und Kieselsäure (Silica), in zweier oder dreier Kombinationen Preparations (pharmaceuticals, disinfectants, care and hygiene products, wound therapeutics) with carvacrol, shea butter and silica (silica), in two or three combinations |
| 05/10/2007 | DE102006051391A1 Cosmetic and/or pharmaceutical composition, useful e.g. to treat aged skin and wrinkles, comprises e.g. lanolin, glycerin, urea, palmitoyl pentapeptide, vitamin-A and tocopherol derivatives, grape seed oil and coenzyme Q10 |
| 05/10/2007 | DE102005053090A1 Verwendung eines aktivierten Zeolithen als pharmazeutisches Mittel für die Reduzierung giftiger Stoffe Using an activated zeolite as a pharmaceutical agent for the reduction of toxic substances |
| 05/10/2007 | CA2616915A1 Depigmenting composition for the skin, comprising adapalene, at least one depigmenting agent and at least one anti-inflammatory agent |
| 05/09/2007 | EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/09/2007 | EP1782824A2 Diaminooxidase-containing pharmaceutical preparations |
| 05/09/2007 | EP1782806A1 Compositions for treating dermatological and neurological disorders |
| 05/09/2007 | EP1782800A2 JAK/STAT pathway inhibitors and the uses thereof |
| 05/09/2007 | EP1781599A1 Androgen modulators |
| 05/09/2007 | EP1781598A1 Androgen modulators |
| 05/09/2007 | EP1781376A1 Herbal composition |